High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Summary
The purpose of this study is to evaluate the safety and efficacy of High Dose-Rate Brachytherapy in patients with both primary and secondary liver malignancies.
General Information
NCT#: NCT05053555
Study ID: 2020-1255
Trial Phase: Phase I
Trial Sponsor: M.D. Anderson Cancer Center
Therapies Used in This Trial: High dose rate brachytherapy